Search

Brenda Libby Coleman

Examiner (ID: 16325)

Most Active Art Unit
1624
Art Unit(s)
1202, 2611, 1624, 1611
Total Applications
3154
Issued Applications
1970
Pending Applications
485
Abandoned Applications
741

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5748373 [patent_doc_number] => 20060111305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 11/267765 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33946 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111305.pdf [firstpage_image] =>[orig_patent_app_number] => 11267765 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267765
Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof Nov 3, 2005 Abandoned
Array ( [id] => 8232993 [patent_doc_number] => 08198435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Crystal form of N-benzoyl-staurosporine' [patent_app_type] => utility [patent_app_number] => 11/718029 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5934 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198435.pdf [firstpage_image] =>[orig_patent_app_number] => 11718029 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718029
Crystal form of N-benzoyl-staurosporine Nov 2, 2005 Issued
Array ( [id] => 322662 [patent_doc_number] => 07517895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Synthetic diazonamides' [patent_app_type] => utility [patent_app_number] => 11/264502 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13438 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517895.pdf [firstpage_image] =>[orig_patent_app_number] => 11264502 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/264502
Synthetic diazonamides Oct 30, 2005 Issued
Array ( [id] => 5614439 [patent_doc_number] => 20060116367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Novel [1,4]benzodiazepines as vasopressin V2 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/260118 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15170 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116367.pdf [firstpage_image] =>[orig_patent_app_number] => 11260118 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/260118
[1,4]benzodiazepines as vasopressin V2 receptor antagonists Oct 26, 2005 Issued
Array ( [id] => 5688983 [patent_doc_number] => 20060287298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Pharmaceutical for treatment of neurological and neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 11/259583 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21940 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287298.pdf [firstpage_image] =>[orig_patent_app_number] => 11259583 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/259583
Pharmaceutical for treatment of neurological and neuropsychiatric disorders Oct 25, 2005 Abandoned
Array ( [id] => 5410901 [patent_doc_number] => 20090124800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => ' PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/577805 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2450 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124800.pdf [firstpage_image] =>[orig_patent_app_number] => 11577805 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577805
PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES Oct 24, 2005 Abandoned
Array ( [id] => 5814864 [patent_doc_number] => 20060084642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/252025 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10155 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084642.pdf [firstpage_image] =>[orig_patent_app_number] => 11252025 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/252025
Substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives Oct 16, 2005 Issued
Array ( [id] => 5815274 [patent_doc_number] => 20060084801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Halogen substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/252026 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18193 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084801.pdf [firstpage_image] =>[orig_patent_app_number] => 11252026 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/252026
Halogen substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives Oct 16, 2005 Issued
Array ( [id] => 4670446 [patent_doc_number] => 20080045506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Pyrrolidine Derivatives as Histamine Receptors Ligands' [patent_app_type] => utility [patent_app_number] => 11/576968 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35877 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045506.pdf [firstpage_image] =>[orig_patent_app_number] => 11576968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576968
Pyrrolidine Derivatives as Histamine Receptors Ligands Oct 12, 2005 Abandoned
Array ( [id] => 4904552 [patent_doc_number] => 20080113966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Cgrp Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/665523 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69642 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113966.pdf [firstpage_image] =>[orig_patent_app_number] => 11665523 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665523
CGRP receptor antagonists Oct 11, 2005 Issued
Array ( [id] => 5727548 [patent_doc_number] => 20060058309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Respiratory syncytial virus replication inhibitors' [patent_app_type] => utility [patent_app_number] => 11/247392 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25101 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058309.pdf [firstpage_image] =>[orig_patent_app_number] => 11247392 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/247392
Respiratory syncytial virus replication inhibitors Oct 10, 2005 Issued
Array ( [id] => 5716144 [patent_doc_number] => 20060079507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/245736 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16037 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079507.pdf [firstpage_image] =>[orig_patent_app_number] => 11245736 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/245736
Substituted imidazo [1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives Oct 6, 2005 Issued
Array ( [id] => 4461107 [patent_doc_number] => 07879882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Thiazolyl mglur5 antagonists and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/664902 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11639 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879882.pdf [firstpage_image] =>[orig_patent_app_number] => 11664902 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/664902
Thiazolyl mglur5 antagonists and methods for their use Oct 5, 2005 Issued
Array ( [id] => 5881474 [patent_doc_number] => 20060030557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Substituted pyridines having antiangiogenic activity' [patent_app_type] => utility [patent_app_number] => 11/244481 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38623 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030557.pdf [firstpage_image] =>[orig_patent_app_number] => 11244481 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244481
Substituted pyridines having antiangiogenic activity Oct 5, 2005 Abandoned
Array ( [id] => 428689 [patent_doc_number] => 07268123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them' [patent_app_type] => utility [patent_app_number] => 11/244599 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11267 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268123.pdf [firstpage_image] =>[orig_patent_app_number] => 11244599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244599
Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them Oct 5, 2005 Issued
Array ( [id] => 314870 [patent_doc_number] => 07524840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => '7,8-disubstituted pyrazolobenzodiazepines' [patent_app_type] => utility [patent_app_number] => 11/244251 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24002 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524840.pdf [firstpage_image] =>[orig_patent_app_number] => 11244251 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244251
7,8-disubstituted pyrazolobenzodiazepines Oct 4, 2005 Issued
Array ( [id] => 5614437 [patent_doc_number] => 20060116365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Small molecule modulators of cytokine activity' [patent_app_type] => utility [patent_app_number] => 11/238285 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29833 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116365.pdf [firstpage_image] =>[orig_patent_app_number] => 11238285 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238285
Small molecule modulators of cytokine activity Sep 27, 2005 Issued
Array ( [id] => 239616 [patent_doc_number] => 07592333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Loxapine analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/233417 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53963 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592333.pdf [firstpage_image] =>[orig_patent_app_number] => 11233417 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233417
Loxapine analogs and methods of use thereof Sep 20, 2005 Issued
11/162737 HYDROGENOLYTIC DENITRATION OF POLYNITRO COMPOUNDS: PENTANITROHEXAAZAISOWURTZITANE Sep 20, 2005 Abandoned
Array ( [id] => 5808350 [patent_doc_number] => 20060094705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Quetiapine analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/232565 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54152 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094705.pdf [firstpage_image] =>[orig_patent_app_number] => 11232565 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/232565
Quetiapine analogs and methods of use thereof Sep 20, 2005 Issued
Menu